Загрузка видео...

Не удалось загрузить видео

Возникла проблема при загрузке этого видео. Это может быть связано с временными проблемами сети или видео может быть недоступно.

На главную

🚨 BREAKING The first drug where AI designed both the target and the molecule has just published Phase II results in Nature Medicine. Patients with a fatal lung disease gained lung function in 12 weeks. Current treatments only slow the decline. This is different. 🧵 Here's what just happened... show more

Harshi Peiris, Ph.D.

9,500 subscribers

15,649 просмотров • 2 месяцев назад •via X (Twitter)

Anya Rossi• Live Now

Private livecam show

Комментарии: 0

Нет доступных комментариев

Здесь появятся комментарии из оригинального поста

Похожие видео

🚨 BREAKING A drug just moved into Phase 3 trials that could SLOW Parkinson's disease for the first time in history. No treatment today actually stops the disease. Just symptoms. This one targets the ROOT CAUSE. Here's the science — and why it matters 🧵 #Parkinsons #Neuroscience #MedTwitter

🚨 BREAKING A drug just moved into Phase 3 trials that could SLOW Parkinson's disease for the first time in history. No treatment today actually stops the disease. Just symptoms. This one targets the ROOT CAUSE. Here's the science — and why it matters 🧵 #Parkinsons #Neuroscience #MedTwitter

Harshi Peiris, Ph.D.

14,774 просмотров • 4 месяцев назад

BREAKING: Scientists now believe Parkinson's disease may not always start in the brain. In many patients, it may begin in the gut — and travel to the brain via a nerve most people have never heard of. At the same time: → A new drug just reversed brain inflammation in PD patients for the first time in history. → A diabetes drug in the same class as Ozempic slowed Parkinson's motor decline in a New England Journal of Medicine trial. → Fecal transplants are producing lasting motor improvement in randomized controlled trials. None of this is making mainstream news. Here is what is actually happening outside the brain in Parkinson's research right now. 🧵

BREAKING: Scientists now believe Parkinson's disease may not always start in the brain. In many patients, it may begin in the gut — and travel to the brain via a nerve most people have never heard of. At the same time: → A new drug just reversed brain inflammation in PD patients for the first time in history. → A diabetes drug in the same class as Ozempic slowed Parkinson's motor decline in a New England Journal of Medicine trial. → Fecal transplants are producing lasting motor improvement in randomized controlled trials. None of this is making mainstream news. Here is what is actually happening outside the brain in Parkinson's research right now. 🧵

Harshi Peiris, Ph.D.

12,716 просмотров • 4 месяцев назад

🚨 BREAKING Scientists may have just cracked the code on Alzheimer's and Parkinson's — WITH ONE PILL. A drug called Buntanetap was just published in a peer-reviewed journal with Phase 3 data. Phase 3 means that we are on the verge of FDA approval. It targets the ROOT CAUSE of both diseases simultaneously. Here's what you need to know 🧵👇 #Alzheimers #Parkinsons

🚨 BREAKING Scientists may have just cracked the code on Alzheimer's and Parkinson's — WITH ONE PILL. A drug called Buntanetap was just published in a peer-reviewed journal with Phase 3 data. Phase 3 means that we are on the verge of FDA approval. It targets the ROOT CAUSE of both diseases simultaneously. Here's what you need to know 🧵👇 #Alzheimers #Parkinsons

Harshi Peiris, Ph.D.

503,263 просмотров • 3 месяцев назад

BREAKING: A new study published yesterday, July 1st, 2026, in Nature Medicine adds a powerful new tool to the Alzheimer's early-detection toolkit. And it's forcing us to rethink what Alzheimer's "risk" even means. Here's what changed, and why your family history isn't the whole story. 🧵👇 #Alzheimers #Biomarkers

BREAKING: A new study published yesterday, July 1st, 2026, in Nature Medicine adds a powerful new tool to the Alzheimer's early-detection toolkit. And it's forcing us to rethink what Alzheimer's "risk" even means. Here's what changed, and why your family history isn't the whole story. 🧵👇 #Alzheimers #Biomarkers

Harshi Peiris, Ph.D.

13,996 просмотров • 2 месяцев назад

BREAKING 🧬 Scientists just edited a gene in living humans — and LDL "bad" cholesterol dropped by 62%. One injection. One time. No daily pills. Effects lasting 18 months. This isn't science fiction. It's a Phase 1b trial published in the NEJM this week. Here's what just happened 🧵

BREAKING 🧬 Scientists just edited a gene in living humans — and LDL "bad" cholesterol dropped by 62%. One injection. One time. No daily pills. Effects lasting 18 months. This isn't science fiction. It's a Phase 1b trial published in the NEJM this week. Here's what just happened 🧵

Harshi Peiris, Ph.D.

16,167 просмотров • 3 месяцев назад

BREAKING: The FDA approved a cancer drug in 2024 that doesn't use chemotherapy. Instead, it powers up the immune cells you were BORN with. In trials, 62% of patients had all detectable cancer disappear completely. This is not hype. Here's what it actually is — and why it doesn't stop with cancer. 🧵

BREAKING: The FDA approved a cancer drug in 2024 that doesn't use chemotherapy. Instead, it powers up the immune cells you were BORN with. In trials, 62% of patients had all detectable cancer disappear completely. This is not hype. Here's what it actually is — and why it doesn't stop with cancer. 🧵

Harshi Peiris, Ph.D.

148,003 просмотров • 5 месяцев назад

🚨 BREAKING: German researchers treated 15 severe lupus patients with CAR-T therapy. All 15 went into complete remission. Many stopped ALL medication. Now a larger trial just confirmed it — across 3 autoimmune diseases. This might be the biggest shift in autoimmune medicine in decades. 🧵

🚨 BREAKING: German researchers treated 15 severe lupus patients with CAR-T therapy. All 15 went into complete remission. Many stopped ALL medication. Now a larger trial just confirmed it — across 3 autoimmune diseases. This might be the biggest shift in autoimmune medicine in decades. 🧵

Harshi Peiris, Ph.D.

424,373 просмотров • 5 месяцев назад

BREAKING: For the first time in 100+ years, Alzheimer's may not be permanent Scientists just reversed advanced Alzheimer's in mice by restoring brain energy balance, eliminating both plaques AND cognitive decline The drug worked in two different animal models, suggesting "this could translate to humans". Game-changing!!

BREAKING: For the first time in 100+ years, Alzheimer's may not be permanent Scientists just reversed advanced Alzheimer's in mice by restoring brain energy balance, eliminating both plaques AND cognitive decline The drug worked in two different animal models, suggesting "this could translate to humans". Game-changing!!

Harshi Peiris, Ph.D.

76,434 просмотров • 5 месяцев назад

BREAKING: For the first time in 100+ years, Alzheimer's may not be permanent Scientists just reversed advanced Alzheimer's in mice by restoring brain energy balance, eliminating both plaques AND cognitive decline The drug worked in two different animal models, suggesting "this could translate to humans". Game-changing 🧠

BREAKING: For the first time in 100+ years, Alzheimer's may not be permanent Scientists just reversed advanced Alzheimer's in mice by restoring brain energy balance, eliminating both plaques AND cognitive decline The drug worked in two different animal models, suggesting "this could translate to humans". Game-changing 🧠

Harshi Peiris, Ph.D.

243,073 просмотров • 6 месяцев назад

Great news from our team to start the week: positive Phase 2 results for a potential first-in-class medicine discovered and developed entirely in-house at Pfizer Inc.. It has the potential to work differently from anything available today, targeting three drivers of inflammation in a single treatment. This could make a real difference for millions of people living with conditions like atopic dermatitis, COPD, and asthma. We're accelerating toward Phase 3 and excited about what lies ahead. This is the kind of innovation our pipeline is built to deliver. More:

Great news from our team to start the week: positive Phase 2 results for a potential first-in-class medicine discovered and developed entirely in-house at Pfizer Inc.. It has the potential to work differently from anything available today, targeting three drivers of inflammation in a single treatment. This could make a real difference for millions of people living with conditions like atopic dermatitis, COPD, and asthma. We're accelerating toward Phase 3 and excited about what lies ahead. This is the kind of innovation our pipeline is built to deliver. More:

Albert Bourla

11,404 просмотров • 5 месяцев назад

1/14 I just finished 2 weeks of work in the hospital. Here’s a glimpse of what I saw. The kind of things that remind you why medicine is so good. First up: An S4 gallop you could not only hear… but see.

1/14 I just finished 2 weeks of work in the hospital. Here’s a glimpse of what I saw. The kind of things that remind you why medicine is so good. First up: An S4 gallop you could not only hear… but see.

André Martin Mansoor

70,793 просмотров • 6 месяцев назад

BREAKING: Harvard scientists may have just discovered why the brain loses its fight against Alzheimer's ... and a trace mineral found naturally in your brain is at the center of it. This isn't another amyloid paper. It asks a completely different question. And the answer has been hiding in your brain all along 🧵👇

BREAKING: Harvard scientists may have just discovered why the brain loses its fight against Alzheimer's ... and a trace mineral found naturally in your brain is at the center of it. This isn't another amyloid paper. It asks a completely different question. And the answer has been hiding in your brain all along 🧵👇

Harshi Peiris, Ph.D.

37,967 просмотров • 6 месяцев назад

Israel just took a massive leap in the war on cancer. New Phase developed a revolutionary nanotech treatment that uses specially designed nanoparticles to heat and destroy metastatic tumors from the inside, even in hard-to-reach areas, while sparing healthy tissue. The technology is already showing incredible results in clinical trials for late-stage cancer patients. This is precision medicine at the nanoscale, turning the body’s own biology into a targeted weapon against one of humanity’s deadliest diseases. From the lab to saving lives worldwide, Startup Nation at it again. Proud every single day. 🇮🇱 #StartupNation #IsraeliInnovation #Nanotech #CancerTreatment #NewPhase

Israel just took a massive leap in the war on cancer. New Phase developed a revolutionary nanotech treatment that uses specially designed nanoparticles to heat and destroy metastatic tumors from the inside, even in hard-to-reach areas, while sparing healthy tissue. The technology is already showing incredible results in clinical trials for late-stage cancer patients. This is precision medicine at the nanoscale, turning the body’s own biology into a targeted weapon against one of humanity’s deadliest diseases. From the lab to saving lives worldwide, Startup Nation at it again. Proud every single day. 🇮🇱 #StartupNation #IsraeliInnovation #Nanotech #CancerTreatment #NewPhase

Mor Edge Insight

15,196 просмотров • 3 месяцев назад

🚨 SCIENTISTS MAY HAVE FOUND A WAY TO DESTROY VIRUSES WITH SOUND Researchers in Brazil report that high-frequency ultrasound was able to physically damage and destabilize both COVID-19 and influenza viruses in laboratory experiments. Not with chemicals. Not with drugs. With vibration. The idea sounds almost futuristic: target the virus at the exact frequency where its outer structure begins to resonate… until the оболope becomes unstable and ruptures. Like an opera singer shattering glass but at the microscopic level. What makes this so fascinating is that the attack isn’t aimed at the virus’s genetics… it’s aimed at its physical structure. Its shape. Its resonance. Its mechanical weakness. If this technology continues to develop, future medicine may start combining: AI-guided ultrasound targeting non-invasive antiviral therapies precision acoustic medicine frequency-based treatments We may be entering an era where sound itself becomes a medical tool. And that changes how we think about fighting disease entirely. Follow for more future science and medical breakthroughs.

🚨 SCIENTISTS MAY HAVE FOUND A WAY TO DESTROY VIRUSES WITH SOUND Researchers in Brazil report that high-frequency ultrasound was able to physically damage and destabilize both COVID-19 and influenza viruses in laboratory experiments. Not with chemicals. Not with drugs. With vibration. The idea sounds almost futuristic: target the virus at the exact frequency where its outer structure begins to resonate… until the оболope becomes unstable and ruptures. Like an opera singer shattering glass but at the microscopic level. What makes this so fascinating is that the attack isn’t aimed at the virus’s genetics… it’s aimed at its physical structure. Its shape. Its resonance. Its mechanical weakness. If this technology continues to develop, future medicine may start combining: AI-guided ultrasound targeting non-invasive antiviral therapies precision acoustic medicine frequency-based treatments We may be entering an era where sound itself becomes a medical tool. And that changes how we think about fighting disease entirely. Follow for more future science and medical breakthroughs.

TheNewPhysics

17,651 просмотров • 3 месяцев назад

What if you could use #AI to find and accurately excise the culprit cells, quantify >5,000 proteins in each, and find a cure for a life-threatening disease that has no effective treatment? That's the beginning of spatial medicine, a momentous medical advance. In the new Ground Truths Because X auto-suppresses the link, you can find it in my profile

Eric Topol

73,944 просмотров • 1 год назад

🚨 SCIENTISTS JUST DOSED THE FIRST PATIENT IN A TRIAL TO REVERSE CELLULAR AGING IN THE HUMAN EYE. Life Biosciences has begun an FDA-approved clinical trial using cellular reprogramming to regenerate aging neurons in the optic nerve of glaucoma patients. Instead of just slowing vision loss, the goal is to actually reverse aspects of cellular aging in the eye essentially trying to make old nerve cells young again. Why this matters: • Glaucoma is one of the leading causes of irreversible blindness worldwide, caused by damage to the optic nerve • Current treatments can only slow progression they cannot regenerate lost vision • This approach uses partial cellular reprogramming (a controlled form of turning back the biological clock) • If successful, it could open the door to treating many other age-related neurodegenerative diseases The deeper implication is enormous: We may be entering an era where aging itself becomes treatable not just its symptoms. If we can safely reprogram cells in the eye, the same technology could eventually be applied to the brain, spine, and other organs. The first patient has now been dosed. This is no longer just theory. What do you think are we ready to start treating aging as a medical condition? Follow for more frontier science and longevity breakthroughs.

🚨 SCIENTISTS JUST DOSED THE FIRST PATIENT IN A TRIAL TO REVERSE CELLULAR AGING IN THE HUMAN EYE. Life Biosciences has begun an FDA-approved clinical trial using cellular reprogramming to regenerate aging neurons in the optic nerve of glaucoma patients. Instead of just slowing vision loss, the goal is to actually reverse aspects of cellular aging in the eye essentially trying to make old nerve cells young again. Why this matters: • Glaucoma is one of the leading causes of irreversible blindness worldwide, caused by damage to the optic nerve • Current treatments can only slow progression they cannot regenerate lost vision • This approach uses partial cellular reprogramming (a controlled form of turning back the biological clock) • If successful, it could open the door to treating many other age-related neurodegenerative diseases The deeper implication is enormous: We may be entering an era where aging itself becomes treatable not just its symptoms. If we can safely reprogram cells in the eye, the same technology could eventually be applied to the brain, spine, and other organs. The first patient has now been dosed. This is no longer just theory. What do you think are we ready to start treating aging as a medical condition? Follow for more frontier science and longevity breakthroughs.

TheNewPhysics

50,500 просмотров • 2 месяцев назад

BREAKING 🚨: THIS IS THE FIRST AI SALES TOOL THAT DOES THE WHOLE JOB. PERIOD. NOT JUST DATA. NOT JUST ENRICHMENT. NOT JUST TEMPLATES. RESEARCH, VERIFICATION, AND A PERSONALIZED COLD EMAIL IN UNDER 2 MINUTES. AUTOGTM BY EXPLEE IS WHAT THE OTHERS PRETEND TO BE.

BREAKING 🚨: THIS IS THE FIRST AI SALES TOOL THAT DOES THE WHOLE JOB. PERIOD. NOT JUST DATA. NOT JUST ENRICHMENT. NOT JUST TEMPLATES. RESEARCH, VERIFICATION, AND A PERSONALIZED COLD EMAIL IN UNDER 2 MINUTES. AUTOGTM BY EXPLEE IS WHAT THE OTHERS PRETEND TO BE.

Hasan Toor

198,359 просмотров • 5 месяцев назад

Today the U.S. FDA approved our medicine – the first and only gene therapy for genetic #hearingloss – signaling a new era where enabling 24/7 natural hearing is now possible. We are proud to make this available for free in the U.S. Read more:

Today the U.S. FDA approved our medicine – the first and only gene therapy for genetic #hearingloss – signaling a new era where enabling 24/7 natural hearing is now possible. We are proud to make this available for free in the U.S. Read more:

Regeneron

249,564 просмотров • 4 месяцев назад

"AI bot that's doing protein folding and literally coming up with cures, doing personalized medicine for cancer patients... you could have the equivalent of like a GoFundMe, but on the blockchain, for people to basically be able to pay an AI bot to cure their cancer." BIOS is built for this. It generates discoveries. Bio Launchpad funds them. Biofy brings validated treatments to patients. Discovery -> funding -> product One system.

"AI bot that's doing protein folding and literally coming up with cures, doing personalized medicine for cancer patients... you could have the equivalent of like a GoFundMe, but on the blockchain, for people to basically be able to pay an AI bot to cure their cancer." BIOS is built for this. It generates discoveries. Bio Launchpad funds them. Biofy brings validated treatments to patients. Discovery -> funding -> product One system.

Bio Protocol

11,107 просмотров • 6 месяцев назад